Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neuroblastoma × Pharmaceutical Preparations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pleural Effusion, Malignant 2 Mesothelioma, Malignant 2 Breast Neoplasms 2 Recurrence 1 Rare Malignant Neoplasm 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Melanoma 1 Lymphoma 1 Lymphedema 1 Immunoglobulin Light-chain Amyloidosis 1 Hereditary Sensory and Autonomic Neuropathies 1 Head and Neck Neoplasms 1 Gynecological Cancers 1 Fibrosis 1 Fallopian Tube Neoplasms 1 Dysplastic Nevus Syndrome 1 Complicated Adrenal Tumor Diseases 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 BRAF V600 Colorectal Cancer 1 Anxiety Disorders 1

Interventions

Temozolomide 16 Irinotecan 12 Cyclophosphamide 11 dinutuximab 8 naxitamab 7 Vincristine 7 Carboplatin 6 sargramostim 5 Melphalan 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Etoposide 5 fludarabine 4 Topotecan 4 Thiotepa 4 Eflornithine 4 Doxorubicin 4 Cisplatin 4 lutetium Lu 177 dotatate 3 etoposide phosphate 3 Zoledronic Acid 3 Specimen Handling 3 Isotretinoin 3 Granulocyte Colony-Stimulating Factor 3 saponin QA-21V1 2 aldesleukin 2 Vorinostat 2 Stem Cell Transplantation 2 Radiation 2 Platinum 2 Mesna 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07334301 2026-01-12

BEACON2

University of Birmingham

Phase 1/2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡